New sedative may cut delirium risk in ventilated kids

NCT ID NCT07542990

Not yet recruiting Symptom relief Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether dexmedetomidine, a sedative, can lower the chance of delirium (sudden confusion) in children who need a breathing machine in the ICU. About 266 children aged 1 month to 17 years will be randomly assigned to receive either dexmedetomidine or the standard drug midazolam. The main goal is to see if fewer children experience delirium with dexmedetomidine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELIRIUM IN THE INTENSIVE CARE UNIT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

delirium prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELIRIUM IN THE INTENSIVE CARE UNIT

Contacts and locations

Locations

CHU d'Angers

Angers, 49933, France
CHU de Caen

Caen, 14033, France
CHU de Lille

Lille, 59120, France
CHU de Marseille

Marseille, 13385, France
CHU de Nantes

Nantes, 44093, France
CHU de Strasbourg

Strasbourg, 67200, France
CHU de Tours

Tours, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.